Sapiens International (NASDAQ:SPNS) Cut to “Buy” at StockNews.com

StockNews.com lowered shares of Sapiens International (NASDAQ:SPNSFree Report) from a strong-buy rating to a buy rating in a research report released on Tuesday.

A number of other equities research analysts also recently commented on SPNS. The Goldman Sachs Group lifted their price target on shares of Sapiens International from $38.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, August 2nd. Needham & Company LLC decreased their target price on shares of Sapiens International from $44.00 to $35.00 and set a “buy” rating on the stock in a research report on Tuesday, November 12th. Finally, Barclays reduced their price target on Sapiens International from $38.00 to $30.00 and set an “underweight” rating on the stock in a research note on Tuesday, November 12th.

Get Our Latest Stock Analysis on Sapiens International

Sapiens International Stock Performance

Shares of SPNS stock opened at $27.62 on Tuesday. Sapiens International has a 52-week low of $25.30 and a 52-week high of $41.22. The stock’s 50-day moving average price is $35.31 and its 200 day moving average price is $35.27. The company has a quick ratio of 2.18, a current ratio of 2.18 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.54 billion, a PE ratio of 21.75 and a beta of 1.25.

Sapiens International (NASDAQ:SPNSGet Free Report) last posted its quarterly earnings data on Monday, November 11th. The technology company reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Sapiens International had a net margin of 13.23% and a return on equity of 17.61%. The firm had revenue of $137.00 million during the quarter, compared to analysts’ expectations of $140.10 million. During the same quarter last year, the business earned $0.32 earnings per share. The business’s quarterly revenue was up 4.8% on a year-over-year basis. As a group, equities research analysts forecast that Sapiens International will post 1.41 EPS for the current year.

Institutional Investors Weigh In On Sapiens International

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Morgan Dempsey Capital Management LLC raised its stake in Sapiens International by 9.5% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,206 shares of the technology company’s stock valued at $143,000 after purchasing an additional 365 shares during the period. Foyston Gordon & Payne Inc raised its stake in Sapiens International by 8.2% during the 2nd quarter. Foyston Gordon & Payne Inc now owns 7,317 shares of the technology company’s stock valued at $248,000 after purchasing an additional 556 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Sapiens International by 5.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,328 shares of the technology company’s stock worth $384,000 after purchasing an additional 569 shares in the last quarter. National Bank of Canada FI acquired a new position in Sapiens International in the third quarter worth about $26,000. Finally, Financial Management Professionals Inc. boosted its stake in shares of Sapiens International by 57.9% in the 3rd quarter. Financial Management Professionals Inc. now owns 1,945 shares of the technology company’s stock valued at $72,000 after purchasing an additional 713 shares in the last quarter. 30.73% of the stock is currently owned by institutional investors.

About Sapiens International

(Get Free Report)

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.

Featured Articles

Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.